Skip to content
AnalystLens

Constellation Energy 8-K Report, Financial Results (Nov 7, 2025)

Reports
Earnings & Results·Regulation FD·Exhibits & Filings
Filing Date
Filed November 7, 2025
Period End
November 7, 2025
Security
CEG
In the record · 2022–202610-K510-Q148-K70

CEG filed 5 annual reports (10-K), 14 quarterly reports (10-Q) and 70 current reports (8-K) between 2022 and 2026.

  1. Material agreement8-K · Aug ’22Aug ’22
  2. Leadership change8-K · Aug ’23Aug ’23
  3. Leadership change8-K · Aug ’26Aug ’26

01—Abstract

Summary

Summary of the 8-K filed November 7, 2025. Cited figures are marked; the original filing is the authoritative source.

Constellation Energy (CEG) reported third-quarter 2025 results on November 7, 2025, with GAAP net income of $930 milliona, or $2.97 per diluted share, down from $3.82 a year earlier.

Adjusted (non-GAAP) operating earnings rose to $952 millionb, or $3.04 per share, versus $2.74 in Q3 2024. Management attributed the improvement to favorable market and portfolio conditions and fewer nuclear outage days, partly offset by lower nuclear production tax credit (PTC) revenue because of higher expected gross receipts for the year. Total operating revenues were essentially flat at $6.57 billion, while operating income fell to $1.09 billion from $1.47 billion, mainly because of the swing in mark-to-market and other items that the company excludes from adjusted earnings.

The company narrowed its full-year 2025 adjusted operating earnings guidance to $9.05c–$9.45 per share, from the original $8.90–$9.60 range, with the midpoint of $9.25 unchanged. Management cited commercial outperformance and nuclear overperformance, partly offset by higher O&M from stock compensation. Nuclear output was 46,477 GWh, up from 45,510 GWh, and the company reported a 96.8% capacity factor for the fleet excluding Salem and STP.

The filing's main strategic items are the pending Calpine acquisition, which management says remains on track to close in Q4 2025, and the settlement with Maryland that clears the way for re-licensing and continued operation of the Conowingo Dam hydroelectric facility. Acquisition-related costs of $28 milliond after tax were excluded from adjusted earnings in the quarter. Liquidity remained solid, with cash of $3.96 billion at quarter end, and the company plans to upsize its credit facility to $7.0 billion effective at the Calpine closing.

Short-term borrowings of $1.65 billion were also outstanding at September 30, 2025. The company is furnishing this information under Items 2.02 and 7.01, so it is not treated as filed for Exchange Act liability purposes.

02—Key points

Key Highlights

  1. GAAP EPS of $2.97 vs. $3.82 in Q3 2024; adjusted operating EPS of $3.04 vs. $2.74, up about 11% year over year.
  2. Full-year 2025 adjusted operating EPS guidance narrowed to $9.05–$9.45 (midpoint $9.25 unchanged from the original range), citing commercial outperformance and nuclear overperformance, offset by higher stock-based compensation O&M.
  3. Nuclear fleet generated 46,477 GWh in Q3 2025 (vs. 45,510 GWh), with a 96.8% capacity factor excluding Salem and STP and only 5 non-refueling outage days versus 20 a year earlier.
  4. Conowingo Dam received a Maryland water quality certification following a settlement, clearing the way for 50 more years of hydro operation (about 572 MW).
  5. Calpine acquisition remains on track to close in Q4 2025; the credit facility will be upsized to $7.0 billion from $4.5B at closing.
  6. Q3 GAAP operating income declined to $1.09B from $1.47B, and interest expense was lower at $134M vs. $147M; the GAAP swing reflects mark-to-market and other non-operating items excluded from adjusted earnings.
  7. Management reiterated a long-term base earnings growth target of 13%+ through 2030, a dividend growth target of 10% annually, and an unchanged capital allocation framework after the Calpine deal.

03—Questions

Frequently Asked Questions

  1. Why did GAAP earnings fall year over year while adjusted earnings rose?

    GAAP net income per share dropped to $2.97 from $3.82 mainly because of non-cash, fair-value-driven items that the company excludes from adjusted results, such as mark-to-market changes on hedges and nuclear decommissioning trust gains and losses. Adjusted operating earnings rose to $3.04 from $2.74 on stronger nuclear performance, fewer outage days, and better commercial and market conditions.

  2. Did Constellation change its 2025 earnings outlook?

    It narrowed the adjusted operating earnings guidance to $9.05–$9.45 per share from $8.90–$9.60. The midpoint stayed at $9.25. Management said commercial performance and nuclear output were ahead of plan, partly offset by higher O&M tied to stock compensation.

  3. What is the status of the Calpine transaction?

    Management said the Calpine acquisition remains on track to close in Q4 2025. Acquisition-related costs of $28 million after tax were excluded from adjusted Q3 results. The company also plans to increase its credit facility to $7.0 billion effective at closing.

  4. How is the Conowingo Dam settlement relevant to investors?

    The settlement with Maryland regulators and environmental groups resolves the outstanding water quality certification issues, allowing re-licensing and continued operation of the hydro facility for decades. Commitments include operational improvements, debris removal, aquatic life passage, and water quality measures. It removes a regulatory overhang on the asset.

  5. Is the company's balance sheet and cash position a concern?

    Cash and equivalents were $3.96 billion at September 30, 2025, and the company had $1.65 billion of short-term borrowings. Ratings were Baa1 (Moody's) and BBB+ (S&P), both stable. Management stated it intends to keep strong investment-grade metrics while pursuing growth and returning capital to shareholders.

04—Continue

← View all 8-K filings